Dual Sodium Channel Blocker/KCa2 Channel Activator (University of California Davis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDual Sodium Channel Blocker/KCa2 Channel Activator (University of California Davis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonistsSodium channels blockers
TargetsPotassium channelSodium channels
Therapy Area/IndicationsNeuralgiaAtaxiaEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of California Davis
Active IndicationsN/A
Inactive IndicationsNeuralgiaAtaxiaEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A